Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver-Reference-Cited by-同舟云学术

Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver

Published:2017-10-17 Issue: Volume:8 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Alves Claudia C.,Waitzberg Dan L.,de Andrade Laila S.,dos Santos Aguiar Laís,Reis Milene B.,Guanabara Camila C.,Júnior Odair A.,Ribeiro Daniel A.,Sala Priscila

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference50 articles.

1. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).;Ahmed;Drug Discov. Today.,2007

2. Dietary soluble fiber and cholesterol affect serum cholesterol concentration, hepatic portal venous short-chain fatty acid concentrations and fecal sterol excretion in rats.;Arjmandi;J Nutr.,1992

3. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.;Bäckhed;Proc. Natl. Acad. Sci. U.S.A.,2007

4. PPARs: transcription factors controlling lipid and lipoprotein metabolism.;Bocher;Ann. N. Y. Acad. Sci.,2002

5. The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD).;Buzzetti;Metabolism,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials;Pharmacological Research;2024-10

2. Probiotics—role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review;Frontiers in Nutrition;2024-08-30

3. Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model;Lipids in Health and Disease;2024-08-24

4. Role of FXR in the development of NAFLD and intervention strategies of small molecules;Archives of Biochemistry and Biophysics;2024-07

5. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways;Journal of Ethnopharmacology;2024-07